Imbalanced NK cell subpopulations and TIGIT expression limit cetuximab efficacy in colorectal cancer: A promising target for treatment enhancement.

ABSTRACT:

SUBMITTER: Navarrete-Sirvent C 

PROVIDER: S-EPMC12148951 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature